RecruitingNCT06506734

Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

Prevalence of Dental Dyschromia and Impact on the Quality of Life of Participants With Prolonged Hyperbilirubinemia During Their Early Years


Sponsor

University Hospital, Toulouse

Enrollment

120 participants

Start Date

Apr 7, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The main objective of this study is to assess the prevalence of dental discoloration (dental dyschromia) in children who experienced high levels of bilirubin in their blood (hyperbilirubinemia) during their early years. The study will also examine risk factors associated with this condition, such as the duration and severity of hyperbilirubinemia, underlying diseases, and treatments received. The researchers hypothesize that the quality of life of individuals with dental dyschromia is lower than that of individuals without dyschromia. The results of this study will be used to discuss coverage for dental care with health insurance for children affected by this condition.


Eligibility

Min Age: 12 YearsMax Age: 18 Years

Inclusion Criteria2

  • A patient with biliary atresia, progressive familial intrahepatic cholestasis, or Alagille syndrome
  • Patient or legal representative not opposed to participating in this research.

Exclusion Criteria1

  • Inability to understand and respond to quality of life questionnaires

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuestionnaires

* " Psychosocial Impact of Dental Aesthetics Questionnaire " PMID 24280547 * " Orofacial Esthetic Scale " PMID 30856637 * " Orofacial Esthetic Scale " PMID 34231057 * A photograph of the patient's smile will be sent to 2 dentists who will also assess the presence or absence of dental dyschromia.


Locations(9)

University Hospital Bordeaux

Bordeaux, France

University Hosptial Caen

Caen, France

University Hospital Lille

Lille, France

Hospices Civils de Lyon

Lyon, France

University Hospital Marseille

Marseille, France

Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, FHU Hépatinov

Paris, France

Assistance Publique-Hôpitaux de Paris, Hôpital Bretonneau, Paris

Paris, France

Assistance Publique-Hôpitaux de Paris, Hôpital Necker

Paris, France

University Hospital Rennes

Rennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06506734


Related Trials